Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3971663
Max Phase: Preclinical
Molecular Formula: C43H45Cl2FN6O7S
Molecular Weight: 879.84
Molecule Type: Small molecule
Associated Items:
ID: ALA3971663
Max Phase: Preclinical
Molecular Formula: C43H45Cl2FN6O7S
Molecular Weight: 879.84
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cnc(OCC5(F)CCOCC5)c(Cl)c4)c(Oc4cccc5[nH]ncc45)c3)CC2)CO1
Standard InChI: InChI=1S/C43H45Cl2FN6O7S/c1-42(2)22-34(28-6-8-30(44)9-7-28)29(26-58-42)25-51-14-16-52(17-15-51)31-10-11-33(39(20-31)59-38-5-3-4-37-35(38)24-48-49-37)40(53)50-60(54,55)32-21-36(45)41(47-23-32)57-27-43(46)12-18-56-19-13-43/h3-11,20-21,23-24H,12-19,22,25-27H2,1-2H3,(H,48,49)(H,50,53)
Standard InChI Key: NHOKPADXJUQJEP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 879.84 | Molecular Weight (Monoisotopic): 878.2432 | AlogP: 7.85 | #Rotatable Bonds: 12 |
Polar Surface Area: 148.21 | Molecular Species: ACID | HBA: 11 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.13 | CX Basic pKa: 7.69 | CX LogP: 4.84 | CX LogD: 5.01 |
Aromatic Rings: 5 | Heavy Atoms: 60 | QED Weighted: 0.13 | Np Likeness Score: -1.14 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):